| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.58B | 34.58B | 34.49B | 32.81B | 31.64B | 34.69B |
| Gross Profit | 6.99B | 6.99B | 7.13B | 5.39B | 6.04B | 9.71B |
| EBITDA | 2.66B | 3.00B | 3.09B | 1.74B | 2.18B | 3.65B |
| Net Income | 746.19M | 746.87M | 957.48M | 84.12M | 565.36M | 2.68B |
Balance Sheet | ||||||
| Total Assets | 30.41B | 30.41B | 31.39B | 30.68B | 25.30B | 22.22B |
| Cash, Cash Equivalents and Short-Term Investments | 1.10B | 1.10B | 3.22B | 1.41B | 2.32B | 1.32B |
| Total Debt | 9.94B | 9.94B | 10.24B | 11.50B | 5.61B | 3.92B |
| Total Liabilities | 15.50B | 15.50B | 16.89B | 17.10B | 11.43B | 8.63B |
| Stockholders Equity | 14.83B | 14.83B | 14.50B | 13.58B | 13.86B | 13.59B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -996.47M | 3.12B | -5.54B | -687.72M | 861.82M |
| Operating Cash Flow | 0.00 | 1.56B | 5.20B | -1.02B | 1.80B | 2.42B |
| Investing Cash Flow | 0.00 | -2.62B | -1.74B | -3.95B | -2.22B | -688.19M |
| Financing Cash Flow | 0.00 | -1.05B | -1.65B | 4.05B | 1.41B | -1.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥9.53B | 11.83 | ― | 2.40% | -0.37% | -54.58% | |
68 Neutral | ¥19.47B | 18.12 | ― | 1.73% | 7.66% | 2.64% | |
64 Neutral | ¥19.60B | 13.40 | ― | 3.14% | -0.73% | 23.36% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥14.53B | 23.36 | ― | 1.90% | 2.59% | 21.25% | |
59 Neutral | ¥13.77B | 22.30 | ― | 1.61% | 0.48% | -34.95% | |
49 Neutral | ¥12.31B | 80.90 | ― | 0.82% | 4.28% | ― |
Ichimasa Kamaboko Co., Ltd. reported its consolidated financial results for the three months ending September 30, 2025, showing a slight increase in net sales by 1.2% year-on-year to ¥7,433 million. However, the company faced operating and ordinary losses, with a profit attributable to owners of the parent at a negative ¥121 million. Despite these challenges, the company forecasts a positive outlook for the fiscal year ending June 30, 2026, with expected increases in net sales and profits, indicating potential recovery and growth.